Recent analysis of ACH member data shows that one in every four 340B dollars supports care for rural Americans. These resources are reinvested directly into patient services, including:
ACH supports reform that strengthens transparency and accountability without restricting CHC participation or reducing patient access to affordable medications.
The current reach of the Community Health Center Program would not be possible without the 340B Drug Discount Program. Data has shown that health centers’ grants and payer reimbursements consistently fail to cover the cost of the comprehensive services provided in the CHC environment. In fact, when Congress created the 340B program in 1992, they recognized this reality – that the 340B drug pricing program would allow safety net providers to “stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.”
By allowing the purchase of drugs at a discounted price, the 340B program enables health centers and other covered entities to funnel the resulting savings into serving more patients with highly complex clinical and social needs than they otherwise could. In today’s economic environment, health centers depend on the 340B program to meet their mission, putting every dollar received back into the communities they serve.
ACH urges Congress to strengthen and sustain the 340B Drug Discount Pricing Program by:
1. Protect CHCs against the 340B Rebate Model, which delays savings and creates costly administrative burdens.
2. Preserve full access to contract pharmacies, ensuring patients can obtain affordable medications where they live.
3. Prevent discriminatory pharmacy benefit managers (PBM) and insurer practices that reduce or divert 340B savings.
4. Strengthen federal oversight and enforcement to uphold congressional intent and program integrity.